Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
117.67
+4.11 (3.62%)
Apr 24, 2026, 11:04 AM EDT - Market open
Celcuity Market Cap
Celcuity has a market cap or net worth of $5.69 billion as of April 24, 2026. Its market cap has increased by 1,730.63% in one year.
Market Cap
5.69B
Enterprise Value
5.42B
1-Year Change
1,730.63%
Ranking
Category
Stock Price
$117.67
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $5.69B, an increase of 4,147.78%. That is a compound annual growth rate of 54.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 5.49B | 18.94% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 6.30B |
| Centessa Pharmaceuticals | 6.10B |
| Terns Pharmaceuticals | 6.10B |
| Immunovant | 6.00B |
| CG Oncology | 5.90B |
| PTC Therapeutics | 5.86B |
| Cogent Biosciences | 5.86B |
| Rhythm Pharmaceuticals | 5.82B |